Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

China’s State FDA Says Merck Recalled Meningitis Vaccine (China)

This article was originally published in PharmAsia News

Executive Summary

China's State FDA says U.S. drug maker Merck has recalled its Pedvaxhib (haemophilus b) conjugate vaccine for preventing meningitis and other diseases because of a sterilization problem in one of its U.S. factories. Merck said it recalled Pedvaxhib and similar Comvax vaccines after it discovered the sterilization problem in its Pennsylvania factory. No cases of children receiving Hib for preventing meningitis, pneumonia and other infections were reported, although infections usually take at least a week to develop. Hib is combined with a hepatitis B vaccine to prevent the other diseases. (Click here for more
Advertisement
Advertisement
UsernamePublicRestriction

Register

SC065885

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel